NXT-ID, Inc., (NXTD) a biometric authentication company focused on the growing m-commerce market announces the roll out of the first 30 second ads to be aired on CNBC starting the week of May 12th. The consumer ads will feature the company’s next generation smart wallet, Wocket™, created to securely replace all the credit cards and loyalty cards in your wallet.… Read more
SurePure, Inc. (SURP) a global leader in liquid photopurification, today announced a breakthrough in the microbiological purification of contaminated marine diesel fuel, using SurePure’s technology as an alternative to biocide addition or excessive micro-filtration.
The contamination of diesel fuel is a significant problem for the maritime shipping industry, leading to extensive waste of fuel and environmental contamination. The industry is seeking … Read more
Champions Oncology, Inc. (CSBR)
WST: Can you begin with a brief overview of Champions Oncology’s business?
Mr. Ackerman: We are in the business of personalizing both the treatment as well as the development of drugs for oncology. One of the major problems in oncology today is most patients get little or no benefit from most of the drugs they take. The fundamental reason is the … Read more
Athersys, Inc. (ATHX) will release its first quarter 2014 financial results at approximately 4:00 PM (Eastern Time) on Thursday, May 8, 2014, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
Targeted Medical Pharma (TRGM), today announced the completion of an agreement between Analytical Testing Laboratories (ATL), a Lebanon based company that specializes in drug testing services and inborn errors of metabolism, for the exclusive distribution of the company’s amino acid based products to physicians and pharmacies throughout the Middle East.
The Agreement provides ATL with a limited exclusive license for the marketing and … Read more
CollabRx, Inc. (CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology, and Affymetrix, Inc. (AFFX), an industry leader in genomics analysis, today announced an agreement to optimize the use of CollabRx’s Genetic Variant Annotation (GVA) Service(TM) in connection with Affymetrix’ OncoScan(TM) FFPE Assay Kit and CytoScan(R) Cytogenetics Suite … Read more
Champions Oncology Treating cancer has long been a trial and error process for doctors, but Champions Oncology is hoping to take the guess work out of choosing the right therapy through the use of its mouse avatars. The company engrafts a patient’s tumor in mice to determine what drugs are most effective. We spoke to Joel Ackerman, CEO of Champions Oncology, about the personalization of … Read more